100
Participants
Start Date
June 25, 2024
Primary Completion Date
December 31, 2026
Study Completion Date
March 31, 2027
BYON4413
BYON4413 will be administered by IV infusion.
RECRUITING
Het Ziekenhuisnetwerk Antwerpen, Antwerp
RECRUITING
UZ Leuven, Leuven
RECRUITING
Universitair Medisch Centrum Groningen, Groningen
RECRUITING
Institut Catala d'Oncologia, Badalona
RECRUITING
Hospital Clinic de Barcelona, Barcelona
RECRUITING
Hospital de la Santa Creu i Sant Pau, Barcelona
RECRUITING
Hospital San Pedro de Alcantara, Cáceres
RECRUITING
Hospital Universitario de Salamanca, Salamanca
RECRUITING
Hospital Universitario y Politecnico La Fe, Valencia
Lead Sponsor
Byondis B.V.
INDUSTRY